{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:56:40Z","timestamp":1794308200086,"version":"4.9.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK040561"],"award-info":[{"award-number":["P30 DK040561"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U24 DK132733"],"award-info":[{"award-number":["U24 DK132733"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UE5 DK137285"],"award-info":[{"award-number":["UE5 DK137285"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K12DK133995"],"award-info":[{"award-number":["K12DK133995"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["9-24-JDFWH-01"],"award-info":[{"award-number":["9-24-JDFWH-01"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Heart Association\u2013Bristol Myers Squibb Foundation","award":["Winn Diversity in Clinical Trials Clinical Investigator Leadership Award"],"award-info":[{"award-number":["Winn Diversity in Clinical Trials Clinical Investigator Leadership Award"]}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","award":["MGH Physician-Scientist Development Award"],"award-info":[{"award-number":["MGH Physician-Scientist Development Award"]}],"id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40272-026-00746-5","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:01:23Z","timestamp":1775102483000},"page":"239-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["GLP-1 Receptor Agonist Use Across Preconception, Pregnancy, and the Postpartum Periods"],"prefix":"10.1007","volume":"28","author":[{"given":"Florence","family":"Porterfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9479-7695","authenticated-orcid":false,"given":"Serena Michelle","family":"Ogunwole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9836-3448","authenticated-orcid":false,"given":"Jacqueline","family":"Maya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4616-533X","authenticated-orcid":false,"given":"Fatima Cody","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"4","key":"746_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s13679-021-00453-x","volume":"10","author":"AJ Cooper","year":"2021","unstructured":"Cooper AJ, Gupta SR, Moustafa AF, Chao AM. Sex\/gender differences in obesity prevalence, comorbidities, and treatment. Curr Obes Rep. 2021;10(4):458\u201366.","journal-title":"Curr Obes Rep"},{"issue":"2","key":"746_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.fertnstert.2024.04.036","volume":"122","author":"SB Schon","year":"2024","unstructured":"Schon SB, Cabre HE, Redman LM. The impact of obesity on reproductive health and metabolism in reproductive-age females. Fertil Steril. 2024;122(2):194\u2013203.","journal-title":"Fertil Steril"},{"issue":"1","key":"746_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.57232","volume":"8","author":"P Berning","year":"2025","unstructured":"Berning P, Adhikari R, Schroer AE, Jelwan YA, Razavi AC, Blaha MJ, et al. Longitudinal analysis of obesity drug use and public awareness. JAMA Netw Open. 2025;8(1):e2457232-e.","journal-title":"JAMA Netw Open"},{"key":"746_CR4","doi-asserted-by":"publisher","first-page":"1280692","DOI":"10.3389\/fendo.2024.1280692","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Lu M, Yi Y, Xia L, Zhang R, Li C, et al. Influence of maternal body mass index on pregnancy complications and outcomes: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024;15:1280692.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"17","key":"746_CR5","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jama.2019.3820","volume":"321","author":"E Voerman","year":"2019","unstructured":"Voerman E, Santos S, Inskip H, Amiano P, LifeCycle Project-Maternal O, Childhood Outcomes Study G, et al. Association of gestational weight gain with adverse maternal and infant outcomes. JAMA. 2019;321(17):1702\u201315.","journal-title":"JAMA"},{"issue":"3","key":"746_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1056\/NEJMra1801040","volume":"387","author":"AA Creanga","year":"2022","unstructured":"Creanga AA, Catalano PM, Bateman BT. Obesity in pregnancy. N Engl J Med. 2022;387(3):248\u201359.","journal-title":"N Engl J Med"},{"issue":"3","key":"746_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/obr.12803","volume":"20","author":"F Najafi","year":"2019","unstructured":"Najafi F, Hasani J, Izadi N, Hashemi-Nazari SS, Namvar Z, Mohammadi S, et al. The effect of prepregnancy body mass index on the risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis. Obes Rev. 2019;20(3):472\u201386.","journal-title":"Obes Rev"},{"issue":"2","key":"746_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1467-789X.2008.00541.x","volume":"10","author":"MR Torloni","year":"2009","unstructured":"Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009;10(2):194\u2013203.","journal-title":"Obes Rev"},{"issue":"8","key":"746_CR9","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.2337\/dc06-2559a","volume":"30","author":"SY Chu","year":"2007","unstructured":"Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30(8):2070\u20136.","journal-title":"Diabetes Care"},{"issue":"1","key":"746_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.orcp.2020.01.004","volume":"14","author":"XJ He","year":"2020","unstructured":"He XJ, Dai RX, Hu CL. Maternal prepregnancy overweight and obesity and the risk of preeclampsia: a meta-analysis of cohort studies. Obes Res Clin Pract. 2020;14(1):27\u201333.","journal-title":"Obes Res Clin Pract"},{"issue":"3","key":"746_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/01.EDE.0000059921.71494.D1","volume":"14","author":"TE O'Brien","year":"2003","unstructured":"O\u2019Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003;14(3):368\u201374.","journal-title":"Epidemiology"},{"issue":"4","key":"746_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2019.100041","volume":"1","author":"R D'Souza","year":"2019","unstructured":"D\u2019Souza R, Horyn I, Pavalagantharajah S, Zaffar N, Jacob CE. Maternal body mass index and pregnancy outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol MFM. 2019;1(4):100041.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"4","key":"746_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/birt.12201","volume":"42","author":"E Declercq","year":"2015","unstructured":"Declercq E, MacDorman M, Osterman M, Belanoff C, Iverson R. Prepregnancy obesity and primary cesareans among otherwise low-risk mothers in 38 U.S. states in 2012. Birth. 2015;42(4):309\u201318.","journal-title":"Birth"},{"issue":"6","key":"746_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1467-789X.2008.00511.x","volume":"9","author":"N Heslehurst","year":"2008","unstructured":"Heslehurst N, Simpson H, Ells LJ, Rankin J, Wilkinson J, Lang R, et al. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev. 2008;9(6):635\u201383.","journal-title":"Obes Rev"},{"key":"746_CR15","unstructured":"In: Rasmussen KM, Yaktine AL, editors. Weight gain during pregnancy: reexamining the guidelines. Washington (DC); 2009."},{"issue":"21","key":"746_CR16","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1001\/jama.2017.3635","volume":"317","author":"RF Goldstein","year":"2017","unstructured":"Goldstein RF, Abell SK, Ranasinha S, Misso M, Boyle JA, Black MH, et al. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. JAMA. 2017;317(21):2207\u201325.","journal-title":"JAMA"},{"issue":"4","key":"746_CR17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/01.AOG.0000278819.17190.87","volume":"110","author":"DW Kiel","year":"2007","unstructured":"Kiel DW, Dodson EA, Artal R, Boehmer TK, Leet TL. Gestational weight gain and pregnancy outcomes in obese women: how much is enough? Obstet Gynecol. 2007;110(4):752\u20138.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"746_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1080\/01443615.2018.1433647","volume":"38","author":"RL Emery","year":"2018","unstructured":"Emery RL, Benno MT, Salk RH, Kolko RP, Levine MD. Healthcare provider advice on gestational weight gain: uncovering a need for more effective weight counselling. J Obstet Gynaecol. 2018;38(7):916\u201321.","journal-title":"J Obstet Gynaecol"},{"issue":"4","key":"746_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/birt.12061","volume":"40","author":"TA Moore Simas","year":"2013","unstructured":"Moore Simas TA, Waring ME, Sullivan GM, Liao X, Rosal MC, Hardy JR, et al. Institute of Medicine 2009 gestational weight gain guideline knowledge: survey of obstetrics\/gynecology and family medicine residents of the United States. Birth. 2013;40(4):237\u201346.","journal-title":"Birth"},{"issue":"4","key":"746_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003486","volume":"18","author":"H Kirkegaard","year":"2021","unstructured":"Kirkegaard H, Bliddal M, St\u00f8vring H, Rasmussen KM, Gunderson EP, K\u00f8ber L, et al. Maternal weight change from prepregnancy to 18 months postpartum and subsequent risk of hypertension and cardiovascular disease in Danish women: a cohort study. PLoS Med. 2021;18(4):e1003486-e.","journal-title":"PLoS Med"},{"issue":"3","key":"746_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2022.100596","volume":"4","author":"BF Abrams","year":"2022","unstructured":"Abrams BF, Leonard SA, Kan P, Lyell DJ, Carmichael SL. Interpregnancy weight change: associations with severe maternal morbidity and neonatal outcomes. Am J Obstet Gynecol MFM. 2022;4(3):100596-.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"4","key":"746_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1053\/j.semperi.2015.05.009","volume":"39","author":"LA Gilmore","year":"2015","unstructured":"Gilmore LA, Klempel-Donchenko M, Redman LM. Pregnancy as a window to future health: excessive gestational weight gain and obesity. Semin Perinatol. 2015;39(4):296\u2013303.","journal-title":"Semin Perinatol"},{"issue":"356","key":"746_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1","volume":"8","author":"PM Catalano","year":"2017","unstructured":"Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017;8(356):j1.","journal-title":"BMJ"},{"issue":"7","key":"746_CR24","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.2337\/dc14-0087","volume":"37","author":"S Kew","year":"2014","unstructured":"Kew S, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, et al. Cardiometabolic implications of postpartum weight changes in the first year after delivery. Diabetes Care. 2014;37(7):1998\u20132006.","journal-title":"Diabetes Care"},{"issue":"19","key":"746_CR25","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1161\/CIR.0000000000001139","volume":"147","author":"LS Mehta","year":"2023","unstructured":"Mehta LS, Velarde GP, Lewey J, Sharma G, Bond RM, Navas-Acien A, et al. Cardiovascular disease risk factors in women: the impact of race and ethnicity: a scientific statement from the American Heart Association. Circulation. 2023;147(19):1471\u201387.","journal-title":"Circulation"},{"issue":"7","key":"746_CR26","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1161\/CIR.0000000000001124","volume":"147","author":"SS Khan","year":"2023","unstructured":"Khan SS, Brewer LC, Canobbio MM, Cipolla MJ, Grobman WA, Lewey J, et al. Optimizing prepregnancy cardiovascular health to improve outcomes in pregnant and postpartum individuals and offspring: a scientific statement from the American Heart Association. Circulation. 2023;147(7):e76\u201391.","journal-title":"Circulation"},{"issue":"2","key":"746_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/GRF.0000000000000349","volume":"61","author":"EA Howell","year":"2018","unstructured":"Howell EA. Reducing disparities in severe maternal morbidity and mortality. Clin Obstet Gynecol. 2018;61(2):387\u201399.","journal-title":"Clin Obstet Gynecol"},{"issue":"18","key":"746_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028409","volume":"12","author":"Z Raisi-Estabragh","year":"2023","unstructured":"Raisi-Estabragh Z, Kobo O, Mieres JH, Bullock-Palmer RP, Van Spall HGC, Breathett K, et al. Racial disparities in obesity-related cardiovascular mortality in the United States: Temporal Trends From 1999 to 2020. J Am Heart Assoc. 2023;12(18):e028409.","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"746_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13747","volume":"25","author":"TL Weir","year":"2024","unstructured":"Weir TL, Majumder M, Glastras SJ. A systematic review of the effects of maternal obesity on neonatal outcomes in women with gestational diabetes. Obes Rev. 2024;25(7):e13747.","journal-title":"Obes Rev"},{"issue":"6","key":"746_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.orcp.2021.10.005","volume":"15","author":"H Vats","year":"2021","unstructured":"Vats H, Saxena R, Sachdeva MP, Walia GK, Gupta V. Impact of maternal pre-pregnancy body mass index on maternal, fetal and neonatal adverse outcomes in the worldwide populations: a systematic review and meta-analysis. Obes Res Clin Pract. 2021;15(6):536\u201345.","journal-title":"Obes Res Clin Pract"},{"issue":"25","key":"746_CR31","doi-asserted-by":"publisher","first-page":"8544","DOI":"10.1080\/14767058.2021.1988563","volume":"35","author":"C Castaneda","year":"2022","unstructured":"Castaneda C, Marsden K, Maxwell T, Ten Eyck P, Kuwaye D, Kenne KA, et al. Prevalence of maternal obesity at delivery and association with maternal and neonatal outcomes. J Matern Fetal Neonatal Med. 2022;35(25):8544\u201351.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"746_CR32","doi-asserted-by":"publisher","first-page":"38680","DOI":"10.1038\/s41598-025-22497-y","volume":"15","author":"YJ Kim","year":"2025","unstructured":"Kim YJ, Shin J, Kim TE, Park S, Lee R, Park YM, et al. Association of maternal pre-pregnancy body mass index with neonatal respiratory outcomes: a nationwide population-based cohort study. Sci Rep. 2025;15(1):38680.","journal-title":"Sci Rep"},{"issue":"5","key":"746_CR33","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/all.15598","volume":"78","author":"NA Rosenquist","year":"2023","unstructured":"Rosenquist NA, Richards M, Ferber JR, Li DK, Ryu SY, Burkin H, et al. Prepregnancy body mass index and risk of childhood asthma. Allergy. 2023;78(5):1234\u201344.","journal-title":"Allergy"},{"issue":"7","key":"746_CR34","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1210\/clinem\/dgaa180","volume":"105","author":"JL Josefson","year":"2020","unstructured":"Josefson JL, Catalano PM, Lowe WL, Scholtens DM, Kuang A, Dyer AR, et al. The joint associations of maternal bmi and glycemia with childhood adiposity. J Clin Endocrinol Metab. 2020;105(7):2177\u201388.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"746_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002744","volume":"16","author":"E Voerman","year":"2019","unstructured":"Voerman E, Santos S, Patro Golab B, Amiano P, Ballester F, Barros H, et al. Maternal body mass index, gestational weight gain, and the risk of overweight and obesity across childhood: an individual participant data meta-analysis. PLoS Med. 2019;16(2):e1002744.","journal-title":"PLoS Med"},{"issue":"6","key":"746_CR36","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1097\/AOG.0000000000004395","volume":"137","author":"Obesity in Pregnancy","year":"2021","unstructured":"Obesity in Pregnancy. ACOG Practice Bulletin, Number 230. Obstet Gynecol. 2021;137(6):e128\u201344.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"746_CR37","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.ajog.2006.06.014","volume":"195","author":"MF Sewell","year":"2006","unstructured":"Sewell MF, Huston-Presley L, Super DM, Catalano P. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol. 2006;195(4):1100\u20133.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"746_CR38","doi-asserted-by":"publisher","first-page":"416 e1","DOI":"10.1016\/j.ajog.2007.10.796","volume":"198","author":"HR Hull","year":"2008","unstructured":"Hull HR, Dinger MK, Knehans AW, Thompson DM, Fields DA. Impact of maternal body mass index on neonate birthweight and body composition. Am J Obstet Gynecol. 2008;198(4):416 e1-426.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"746_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002817","volume":"16","author":"N Heslehurst","year":"2019","unstructured":"Heslehurst N, Vieira R, Akhter Z, Bailey H, Slack E, Ngongalah L, et al. The association between maternal body mass index and child obesity: a systematic review and meta-analysis. PLoS Med. 2019;16(6):e1002817.","journal-title":"PLoS Med"},{"issue":"3","key":"746_CR40","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1542\/peds.2004-1808","volume":"115","author":"CM Boney","year":"2005","unstructured":"Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115(3):e290\u20136.","journal-title":"Pediatrics"},{"issue":"5","key":"746_CR41","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3945\/ajcn.2008.27416","volume":"90","author":"PM Catalano","year":"2009","unstructured":"Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, de Mouzon SH, et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr. 2009;90(5):1303\u201313.","journal-title":"Am J Clin Nutr"},{"key":"746_CR42","doi-asserted-by":"crossref","unstructured":"Gagne-Ouellet V, Breton E, Thibeault K, Fortin CA, Cardenas A, Guerin R, et al. Mediation analysis supports a causal relationship between maternal hyperglycemia and placental DNA methylation variations at the leptin gene locus and cord blood leptin levels. Int J Mol Sci. 2020;21(1).","DOI":"10.3390\/ijms21010329"},{"issue":"1","key":"746_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13148-019-0612-6","volume":"11","author":"P Nogues","year":"2019","unstructured":"Nogues P, Dos Santos E, Jammes H, Berveiller P, Arnould L, Vialard F, et al. Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta. Clin Epigenetics. 2019;11(1):20.","journal-title":"Clin Epigenetics"},{"key":"746_CR44","unstructured":"Xenical (Orlistat) FDA Label.2022. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/020766s038lbl.pdf. Accessed 2 Feb 2026."},{"key":"746_CR45","unstructured":"Qsymia (phentermine and topiramate) FDA Label. 2022. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/022580s021lbl.pdf. Accessed 2 Feb 2026."},{"key":"746_CR46","unstructured":"Contrave FDA Label. 2021. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/200063s020lbl.pdf. Accessed 2 Feb 2026."},{"key":"746_CR47","unstructured":"IMCIVREE\u00ae (setmelanotide) FDA Label. 2022. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/213793s001lbl.pdf. Accessed 2 Feb 2026."},{"issue":"6","key":"746_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ajog.2018.02.003","volume":"218","author":"W Kwong","year":"2018","unstructured":"Kwong W, Tomlinson G, Feig DS. Maternal and neonatal outcomes after bariatric surgery; a systematic review and meta-analysis: do the benefits outweigh the risks? Am J Obstet Gynecol. 2018;218(6):573\u201380.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"746_CR49","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.fertnstert.2024.02.038","volume":"122","author":"AE Caldwell","year":"2024","unstructured":"Caldwell AE, Gorczyca AM, Bradford AP, Nicklas JM, Montgomery RN, Smyth H, et al. Effectiveness of preconception weight loss interventions on fertility in women: a systematic review and meta-analysis. Fertil Steril. 2024;122(2):326\u201340.","journal-title":"Fertil Steril"},{"issue":"8","key":"746_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237571","volume":"15","author":"HA Wahabi","year":"2020","unstructured":"Wahabi HA, Fayed A, Esmaeil S, Elmorshedy H, Titi MA, Amer YS, et al. Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes. PLoS ONE. 2020;15(8):e0237571.","journal-title":"PLoS ONE"},{"issue":"9","key":"746_CR51","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1210\/clinem\/dgaf288","volume":"110","author":"JA Wyckoff","year":"2025","unstructured":"Wyckoff JA, Lapolla A, Asias-Dinh BD, Barbour LA, Brown FM, Catalano PM, et al. Preexisting diabetes and pregnancy: an Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. J Clin Endocrinol Metab. 2025;110(9):2405\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"746_CR52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","volume":"184","author":"CE Cesta","year":"2024","unstructured":"Cesta CE, Rotem R, Bateman BT, Chodick G, Cohen JM, Furu K, et al. Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy. JAMA Intern Med. 2024;184(2):144\u201352.","journal-title":"JAMA Intern Med"},{"issue":"11","key":"746_CR53","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989\u20131002.","journal-title":"N Engl J Med"},{"issue":"3","key":"746_CR54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"746_CR55","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eprac.2023.11.007","volume":"30","author":"HUH Ansari","year":"2024","unstructured":"Ansari HUH, Qazi SU, Sajid F, Altaf Z, Ghazanfar S, Naveed N, et al. Efficacy and safety of Glucagon-Like Peptide-1 receptor agonists on body weight and cardiometabolic parameters in individuals with obesity and without diabetes: a systematic review and meta-analysis. Endocr Pract. 2024;30(2):160\u201371.","journal-title":"Endocr Pract"},{"issue":"2","key":"746_CR56","doi-asserted-by":"publisher","first-page":"116 e1","DOI":"10.1016\/j.ajog.2025.01.019","volume":"233","author":"MR Imbroane","year":"2025","unstructured":"Imbroane MR, LeMoine F, Nau CT. Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes. Am J Obstet Gynecol. 2025;233(2):116 e1-e7.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"746_CR57","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s13669-023-00350-1","volume":"12","author":"A Nuako","year":"2023","unstructured":"Nuako A, Tu L, Reyes KJC, Chhabria SM, Stanford FC. Pharmacologic treatment of obesity in reproductive aged WOMEN. Curr Obstet Gynecol Rep. 2023;12(2):138\u201346.","journal-title":"Curr Obstet Gynecol Rep."},{"key":"746_CR58","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000835","author":"E Minis","year":"2023","unstructured":"Minis E, Stanford FC, Mahalingaiah S. Glucagon-like peptide-1 receptor agonists and safety in the preconception period. Curr Opin Endocrinol Diabetes Obes. 2023. https:\/\/doi.org\/10.1097\/MED.0000000000000835.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"746_CR59","doi-asserted-by":"crossref","unstructured":"Carmina E, Longo RA. Semaglutide treatment of excessive body weight in obese PCOS patients unresponsive to lifestyle programs. J Clin Med. 2023;12(18).","DOI":"10.3390\/jcm12185921"},{"issue":"1","key":"746_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.rbmo.2017.03.023","volume":"35","author":"M Nylander","year":"2017","unstructured":"Nylander M, Frossing S, Clausen HV, Kistorp C, Faber J, Skouby SO. Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial. Reprod Biomed Online. 2017;35(1):121\u20137.","journal-title":"Reprod Biomed Online"},{"key":"746_CR61","doi-asserted-by":"crossref","unstructured":"Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al. Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring). 2025.","DOI":"10.1177\/15598276251344827"},{"issue":"2","key":"746_CR62","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.fertnstert.2024.05.154","volume":"122","author":"AS Goldberg","year":"2024","unstructured":"Goldberg AS, Boots CE. Treating obesity and fertility in the era of glucagon-like peptide 1 receptor agonists. Fertil Steril. 2024;122(2):211\u20138.","journal-title":"Fertil Steril"},{"key":"746_CR63","first-page":"1","volume":"1","author":"MF Young","year":"2021","unstructured":"Young MF, Ramakrishnan U. Maternal undernutrition before and during pregnancy and offspring health and development. Ann Nutr Metab. 2021;1:1\u201313.","journal-title":"Ann Nutr Metab"},{"issue":"19","key":"746_CR64","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1080\/10408398.2021.1989658","volume":"63","author":"Y Cui","year":"2023","unstructured":"Cui Y, Liao M, Xu A, Chen G, Liu J, Yu X, et al. Association of maternal pre-pregnancy dietary intake with adverse maternal and neonatal outcomes: a systematic review and meta-analysis of prospective studies. Crit Rev Food Sci Nutr. 2023;63(19):3430\u201351.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"746_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/jama.2023.24945","volume":"331","author":"LJ Aronne","year":"2024","unstructured":"Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38\u201348.","journal-title":"JAMA"},{"issue":"8","key":"746_CR66","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","volume":"24","author":"JPH Wilding","year":"2022","unstructured":"Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the <scp>STEP<\/scp> 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553\u201364.","journal-title":"Diabetes Obes Metab"},{"issue":"14","key":"746_CR67","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2021.3224","volume":"325","author":"D Rubino","year":"2021","unstructured":"Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414\u201325.","journal-title":"JAMA"},{"issue":"3","key":"746_CR68","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jogc.2020.09.023","volume":"43","author":"H Piccinini-Vallis","year":"2021","unstructured":"Piccinini-Vallis H, Woolcott C, Miller L, Snelgrove-Clarke E, Cahill S. The relationship between pre-pregnancy attempts to lose weight and gestational weight gain: an exploratory primary care prospective cohort study. J Obstet Gynaecol Can. 2021;43(3):337-43.e1.","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"746_CR69","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamacardio.2025.0637","volume":"10","author":"SS Khan","year":"2025","unstructured":"Khan SS, Grobman WA, Kazi DS. Periconceptional glucagon-like peptide-1 receptor agonist use and discontinuation. JAMA Cardiol. 2025;10(6):525\u20136.","journal-title":"JAMA Cardiol."},{"issue":"24","key":"746_CR70","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1001\/jama.2025.20951","volume":"334","author":"J Maya","year":"2025","unstructured":"Maya J, Pant D, Fu Y, James K, Batlle C, Hsu S, et al. Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation. JAMA. 2025;334(24):2186\u201396.","journal-title":"JAMA"},{"key":"746_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1215356","volume":"14","author":"DRP Muller","year":"2023","unstructured":"Muller DRP, Stenvers DJ, Malekzadeh A, Holleman F, Painter RC, Siegelaar SE. Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence. Front Endocrinol (Lausanne). 2023;14:1215356.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"746_CR72","unstructured":"Wegovy FDA Label. 2023. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/215256s007lbl.pdf.. Accessed 2 Feb 2026."},{"issue":"1","key":"746_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajog.2024.08.024","volume":"232","author":"RF Drummond","year":"2025","unstructured":"Drummond RF, Seif KE, Reece EA. Glucagon-like peptide-1 receptor agonist use in pregnancy: a review. Am J Obstet Gynecol. 2025;232(1):17\u201325.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"746_CR74","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1111\/dom.16437","volume":"27","author":"CH Parker","year":"2025","unstructured":"Parker CH, Slattery C, Brennan DJ, le Roux CW. Glucagon-like peptide 1 (GLP-1) receptor agonists\u2019 use during pregnancy: safety data from regulatory clinical trials. Diabetes Obes Metab. 2025;27(8):4102\u20138.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"746_CR75","doi-asserted-by":"publisher","first-page":"E268","DOI":"10.1152\/ajpendo.00361.2023","volume":"326","author":"L Qiao","year":"2024","unstructured":"Qiao L, Lu C, Zang T, Dzyuba B, Shao J. Maternal GLP-1 receptor activation inhibits fetal growth. Am J Physiol Endocrinol Metab. 2024;326(3):E268\u201376.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"746_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.70021","volume":"136","author":"L Kolding","year":"2025","unstructured":"Kolding L, Henriksen JN, Saedder EA, Ovesen PG, Pedersen LH. Pregnancy outcomes after Semaglutide exposure. Basic Clin Pharmacol Toxicol. 2025;136(4):e70021.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"746_CR77","doi-asserted-by":"crossref","unstructured":"Morton A, He J. Pregnancy outcomes following first trimester exposure to semaglutide. Obstet Med. 2025; 1753495X251346330.","DOI":"10.1177\/1753495X251346330"},{"issue":"4","key":"746_CR78","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-083550","volume":"14","author":"K Dao","year":"2024","unstructured":"Dao K, Shechtman S, Weber-Schoendorfer C, Diav-Citrin O, Murad RH, Berlin M, et al. Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services. BMJ Open. 2024;14(4):e083550.","journal-title":"BMJ Open"},{"issue":"246","key":"746_CR79","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.amjcard.2025.03.013","volume":"1","author":"M Hanif","year":"2025","unstructured":"Hanif M, Hays AG, Nagarajan JS, Sah SP, Weinstock RS, Taub CC. Efficacy and safety of glucagon-like peptide-1 receptor agonist use during the first trimester in pregnant women with type 2 diabetes. Am J Cardiol. 2025;1(246):10\u20133.","journal-title":"Am J Cardiol"},{"issue":"2","key":"746_CR80","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/jama.2024.22284","volume":"333","author":"SS Khan","year":"2025","unstructured":"Khan SS, Ndumele CE, Kazi DS. Discontinuation of GLUCAGON-like peptide-1 receptor agonists. JAMA. 2025;333(2):113\u20134.","journal-title":"JAMA"},{"issue":"3","key":"746_CR81","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.orcp.2020.04.009","volume":"14","author":"NR Legro","year":"2020","unstructured":"Legro NR, Lehman EB, Kjerulff KH. Mode of first delivery and postpartum weight retention at 1 year. Obes Res Clin Pract. 2020;14(3):241\u20138.","journal-title":"Obes Res Clin Pract"},{"issue":"1","key":"746_CR82","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/AOG.0000000000000565","volume":"125","author":"LK Endres","year":"2015","unstructured":"Endres LK, Straub H, McKinney C, Plunkett B, Minkovitz CS, Schetter CD, et al. Postpartum Weight Retention Risk Factors and Relationship to Obesity at 1 Year. Obstet Gynecol (New York 1953). 2015;125(1):144\u201352.","journal-title":"Obstet Gynecol (New York 1953)"},{"key":"746_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2024.101596","author":"KA Ahrens","year":"2025","unstructured":"Ahrens KA, Palmsten K, Lipkind HS, Ackerman-Banks CM. Prevalence of GLP-1 medication exposure prior to, during, and after pregnancy using state-wide data from 2017 to 2023. Am J Obstet Gynecol MFM. 2025. https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101596.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"24","key":"746_CR84","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1001\/jama.2025.20947","volume":"334","author":"M Bliddal","year":"2025","unstructured":"Bliddal M, Nohmie G, Damkier P, Pottegard A. Increasing postpartum use of GLP-1 receptor agonists. JAMA. 2025;334(24):2227\u20139.","journal-title":"JAMA"},{"key":"746_CR85","doi-asserted-by":"publisher","first-page":"278S","DOI":"10.1093\/advances\/nmy022","volume":"9","author":"DK Dror","year":"2018","unstructured":"Dror DK, Allen LH. Overview of nutrients in human milk. Adv Nutr. 2018;9:278S-94S.","journal-title":"Adv Nutr"},{"key":"746_CR86","doi-asserted-by":"crossref","unstructured":"Diab H, Fuquay T, Datta P, Bickel U, Thompson J, Krutsch K. Subcutaneous semaglutide during breastfeeding: infant safety regarding drug transfer into human milk. Nutrients. 2024;16(17).","DOI":"10.3390\/nu16172886"},{"issue":"6","key":"746_CR87","first-page":"638","volume":"106","author":"JP Spencer","year":"2022","unstructured":"Spencer JP, Thomas S, Trondsen Pawlowski RH. Medication safety in breastfeeding. Am Fam Physician. 2022;106(6):638\u201344.","journal-title":"Am Fam Physician"},{"issue":"4","key":"746_CR88","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"},{"issue":"19","key":"746_CR89","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834\u201344.","journal-title":"N Engl J Med"},{"issue":"10193","key":"746_CR90","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019;394(10193):121\u201330.","journal-title":"Lancet"},{"issue":"24","key":"746_CR91","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221\u201332.","journal-title":"N Engl J Med"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00746-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00746-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00746-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:03:19Z","timestamp":1777291399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-026-00746-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1007\/s40272-026-00746-5","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"F.C.S declares grants from NIH\/NIDDK (P30 DK040561, U24 DK132733, and UE5 DK137285) and consulting fees from Eli Lilly, Novo Nordisk, Amgen, Boehringer Ingelheim, AstraZeneca, AbbVie,\u00a0Currax, Pfizer, Doximity, MelliCell, Vida Health, Empros Pharma, Apnimed, Clearmind Medicine,\u00a0 and Ilant Health, all outside of the current work. F.P., S.M.O, and J.M. are not aware of any affiliations, memberships, funding, or financial holdings that might be perceived as affecting the objectivity of this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All authors (F.P, S.M.O, J.M, F.C.S) meet ICMJE authorship criteria, made substantial contributions to the conception and design of the work and to drafting or critically revising the manuscript, approved the final version, and agree to be accountable for all aspects of the work.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}